No full text
Patent (Patents)
Biomarkers, uses of biomarkers and a method of identifying biomarkers for colorectal carcinoma (CRC) liver metastasis
Castronovo, Vincenzo; Turtoi, Andrei
2012
 

Files


Full Text
No document available.

Send to



Details



Abstract :
[en] The invention relates to the use of one or more of protein myoferlin, protein latent- transforming growth factor beta binding protein 2, protein transforming growth factor beta induced protein ig-h3, protein adipocyte enhancer-binding protein 1, protein EMILINI, protein periostin, protein CD97, protein prolargin, protein Thy-1 membrane glycoprotein, protein growth hormone inducible transmembrane protein, protein biglycan, protein EPCAM and protein EMILIN2 as a biomarker for colorectal carcinoma (CRC) liver metastasis, or a predisposition thereto. The invention aslo relates to ligands directed to the above-mentioned biomarkers, for use in the therapeutic and/or prophylactic treatment of CRC liver metastasis.
Disciplines :
Laboratory medicine & medical technology
Inventor :
Castronovo, Vincenzo ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie générale et cellulaire
Turtoi, Andrei 
Language :
English
Title (54) :
Biomarkers, uses of biomarkers and a method of identifying biomarkers for colorectal carcinoma (CRC) liver metastasis
Publication date (43-45) :
21 June 2012
Filing date (22) :
30 November 2011
Patent/publication number (10-11) :
2012/079978
Patent status (13) :
A
Priority number (30) :
10194777.8
International classification (IPC) (51) :
G01N33/5 74
European classification (ECLA) (52) :
G01N33/57419 G01N33/57484
Applicant (71) :
ULg - Université de Liège
Publication organism (19) :
WIPO
Available on ORBi :
since 03 July 2018

Statistics


Number of views
63 (5 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi